Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Prevention of mother-to-child transmission of HIV at the second immunization visit: a cross-sectional study, Burkina Faso ; Prévention de la transmission du VIH de la mère à l'enfant lors de la seconde visite de vaccination : étude transversale, Burkina Faso

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Centre Muraz Bobo-Dioulasso, Burkina Faso; Pathogenesis and Control of Chronic and Emerging Infections (PCCEI); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles (UA)-Etablissement français du don du sang Montpellier -Université de Montpellier (UM); Inserm Occitanie Méditerranée (Montpellier); Institut National de Santé Publique Ouagadougou (INSP Ouagadougou ); Thrasher Research Fund (Thrasher Award Number 13501).
    • Publication Information:
      CCSD
      World Health Organization
    • Publication Date:
      2022
    • Collection:
      Université des Antilles (UAG): HAL
    • Abstract:
      International audience ; Objective: to evaluate the performance of the cascade of activities for prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) at the second immunization visit in Burkina Faso.Methods: in a cross-sectional study, we recruited mothers attending the second immunization visit for their infant in 20 health centres of Bobo-Dioulasso city, Burkina Faso over 12 months (2019–2020). We administered a short questionnaire to 14 176 mothers and performed HIV serological tests on mothers who had not been tested in the last 3 months. All mothers were asked about their attendance for antenatal care and HIV rapid testing. HIV-infected mothers were also asked about the timing of their HIV diagnosis, antiretroviral therapy, pre-exposure prophylaxis initiation at birth and infant diagnosis of HIV.Findings: of 14 136 respondents, 13 738 (97.2%) had at least one HIV serological test in their lifetime. Of 13 078 mothers who were never tested or were HIV-negative, 12 454 (95.2%) were tested during or after their last pregnancy. Among HIV-infected mothers already aware of their status, 110/111 (99.1%) women were on antiretroviral therapy. Among HIV-exposed infants, 84/101 (83.2%) babies received 6 weeks of antiretroviral prophylaxis at birth and 58/110 (52.7%) had a blood sample collected for early infant diagnosis. Only two mothers received their child’s test results at the time of the second immunization visit. Four mothers were newly diagnosed as HIV-positive during the study.Conclusion: collecting data at the second immunization visit, a visit rarely missed by mothers, could be useful for identifying gaps in the PMTCT cascade in settings where mothers are difficult to reach, such as in low-income countries with intermediate or low HIV prevalence. ; Objectif : évaluer les performances de la cascade d'activités liées à la prévention d'une transmission de la mère à l'enfant (PTME) du virus de l'immunodéficience humaine (VIH) lors de la seconde visite de vaccination au Burkina ...
    • Relation:
      IRD: fdi:010090459
    • Accession Number:
      10.2471/BLT.22.288522
    • Online Access:
      https://hal.science/hal-03894751
      https://hal.science/hal-03894751v1/document
      https://hal.science/hal-03894751v1/file/BLT.22.288522.pdf
      https://doi.org/10.2471/BLT.22.288522
    • Rights:
      http://creativecommons.org/licenses/by/ ; info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.D5D8812F